EnzymeBioSystems
company.status.inactiveCIK 1471968fmd_1DTXBSCTEWZSNQRXGF17AP67DRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2011 to Mar 31, 2018, 12 periods
Latest annual · FY2017
Millions- Operating income
- (0)
- Net income
- (0)
Latest quarter · Q3 FY2018
Millions- Operating income
- (0)
- Net income
- (0)
EnzymeBioSystems financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Operating income | -$110,793 | -$125,359 | 10-K 2017-10-13 · proof | |
| Net income | -$95,793 | -$125,359 | 10-K 2017-10-13 · proof | |
| Cash from operating activities | -$98,793 | -$130,429 | 10-K 2017-10-13 · proof | |
| Total assets | $44,249 | $140,042 | -68.4% | 10-K 2017-10-13 · proof |
| Total liabilities | $4,100 | $4,100 | 0% | 10-K 2017-10-13 · proof |
| Cash and cash equivalents | $41,249 | $140,042 | -70.5% | 10-K 2017-10-13 · proof |
- What was EnzymeBioSystems's operating income in fiscal 2017?
- EnzymeBioSystems reported operating income of -$110,793 for fiscal 2017 (the year ended Jun 30, 2017), against -$125,359 the year before. Source: the 10-K filed with the SEC on Oct 13, 2017. SEC
- What was EnzymeBioSystems's net income in fiscal 2017?
- EnzymeBioSystems reported net income of -$95,793 for fiscal 2017 (the year ended Jun 30, 2017), against -$125,359 the year before. Source: the 10-K filed with the SEC on Oct 13, 2017. SEC
- What was EnzymeBioSystems's cash from operating activities in fiscal 2017?
- EnzymeBioSystems reported cash from operating activities of -$98,793 for fiscal 2017 (the year ended Jun 30, 2017), against -$130,429 the year before. Source: the 10-K filed with the SEC on Oct 13, 2017. SEC
- What are EnzymeBioSystems's total assets?
- As of Jun 30, 2017, EnzymeBioSystems reported total assets of $44,249, against $140,042 a year earlier (-68.4%). Source: the 10-K filed with the SEC on Oct 13, 2017. SEC
- What are EnzymeBioSystems's total liabilities?
- As of Jun 30, 2017, EnzymeBioSystems reported total liabilities of $4,100, against $4,100 a year earlier (0%). Source: the 10-K filed with the SEC on Oct 13, 2017. SEC
- What are EnzymeBioSystems's cash and cash equivalents?
- As of Jun 30, 2017, EnzymeBioSystems reported cash and cash equivalents of $41,249, against $140,042 a year earlier (-70.5%). Source: the 10-K filed with the SEC on Oct 13, 2017. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1471968&period_type=annual&limit=5"Information only, not investment advice.